New Phase 3 Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Complete Skin Clearance and Favorable Joint Efficacy in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years
SPRING HOUSE, PENNSYLVANIA, March 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced long-term data from the Phase 3 DISCOVER-2a study showing that the skin clearance, joint symptom relief, and safety of TREMFYA® (guselkumab) previously demonstrated through 24 weeks and one year (Week 52) in adults with active psoriatic arthritis (PsA) continued through two years (Week 112).1,2 These findings also confirmed that the robust efficacy TREMFYA demonstrated in patients at Week 24 on physical function, physical aspects of health-related quality of life, and resolution of enthesitisb and d...
Source: Johnson and Johnson - March 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Lung cancer symptoms: Bronchitis that won't go away is an early warning sign
LUNG cancer is one of the most common and serious types of cancer, with around 47,000 people diagnosed with the condition every year in the UK. Bronchitis that doesn't go away is an early warning sign. (Source: Daily Express - Health)
Source: Daily Express - Health - February 23, 2021 Category: Consumer Health News Source Type: news
How Do You Know if You Have Bronchitis or COVID-19 (Coronavirus)?
Title: How Do You Know if You Have Bronchitis or COVID-19 (Coronavirus)?Category: Diseases and ConditionsCreated: 2/17/2021 12:00:00 AMLast Editorial Review: 2/17/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 17, 2021 Category: Respiratory Medicine Source Type: news
What Is the Best Medicine and Treatment for Bronchitis?
Title: What Is the Best Medicine and Treatment for Bronchitis?Category: Diseases and ConditionsCreated: 2/16/2021 12:00:00 AMLast Editorial Review: 2/16/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 16, 2021 Category: Respiratory Medicine Source Type: news
Acute Bronchitis Contagoius Symptoms, Causes, Treatment, and Recovery Time
Title: Acute Bronchitis Contagoius Symptoms, Causes, Treatment, and Recovery TimeCategory: Diseases and ConditionsCreated: 9/2/2005 12:00:00 AMLast Editorial Review: 2/9/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 9, 2021 Category: Respiratory Medicine Source Type: news
How Do You Know If Your Child Has Bronchitis?
Title: How Do You Know If Your Child Has Bronchitis?Category: Diseases and ConditionsCreated: 1/21/2021 12:00:00 AMLast Editorial Review: 1/21/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 21, 2021 Category: Respiratory Medicine Source Type: news
Is Bronchitis Contagious Through Kissing?
Title: Is Bronchitis Contagious Through Kissing?Category: Diseases and ConditionsCreated: 1/8/2021 12:00:00 AMLast Editorial Review: 1/8/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 8, 2021 Category: Respiratory Medicine Source Type: news
What Is the Treatment for Asthmatic Bronchitis?
Title: What Is the Treatment for Asthmatic Bronchitis?Category: Diseases and ConditionsCreated: 12/21/2020 12:00:00 AMLast Editorial Review: 12/21/2020 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - December 21, 2020 Category: Respiratory Medicine Source Type: news
How Do You Know if Your Baby has Bronchitis?
Title: How Do You Know if Your Baby has Bronchitis?Category: Diseases and ConditionsCreated: 12/16/2020 12:00:00 AMLast Editorial Review: 12/16/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - December 16, 2020 Category: Respiratory Medicine Source Type: news
What Are the Main Causes of Bronchitis?
Title: What Are the Main Causes of Bronchitis?Category: Diseases and ConditionsCreated: 12/15/2020 12:00:00 AMLast Editorial Review: 12/15/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - December 15, 2020 Category: Respiratory Medicine Source Type: news
Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dose, post-exposure preventive treatment for influenza,” said Le...
Source: Roche Media News - November 24, 2020 Category: Pharmaceuticals Source Type: news
Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dose, post-exposure preventive treatment for influenza,” said Le...
Source: Roche Investor Update - November 24, 2020 Category: Pharmaceuticals Source Type: news
E-cigarette users have 30% higher risk for chronic lung diseases, study finds
E-cigarette users have a roughly 30% higher risk for developing respiratory illness, such as chronic obstructive pulmonary disease, emphysema, chronic bronchitis and asthma than non-users, according to a study in JAMA. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 12, 2020 Category: Consumer Health News Source Type: news
CSA Medical Announces Enrollment Milestone in a Mechanism of Action Study utilizing the RejuvenAir(R) System for COPD Patients with Chronic Bronchitis
This study will provide a scientific rationale for the remodeling response and clinical improvements identified in the feasibility study
BOSTON, Nov. 11, 2020 -- (Healthcare Sales & Marketing Network) -- CSA Medical, Inc., today announced that over hal... Devices CSA Medical, cryotherapy, RejuvenAir, COPD, Bronchitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 11, 2020 Category: Pharmaceuticals Source Type: news
New source of lymphatic system leak discovered in children with rare open heart surgery complication
(Nemours) Interventional radiologists with Nemours Children's Health System have identified a new source of abnormal lymphatic flow between the liver and the lungs that may be responsible for some cases of plastic bronchitis. Plastic bronchitis is a rare but serious late complication in patients with congenital heart disease who had Fontan surgery. A report detailing the discovery of this fluid leak, and successful treatment of two cases was published in European Heart Journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 11, 2020 Category: International Medicine & Public Health Source Type: news
